About Rashmi Kanagal-Shamanna, MD
Dr. Kanagal-Shamanna is a board-certified clinical hematopathologist and molecular genetic pathologist in the Department of Hematopathology and Molecular Diagnostics at the University of Texas MD Anderson Cancer Center. Her research is focused on the characterization of the diagnostic and prognostic biomarkers using novel molecular techniques in hematological malignancies.
Intro Content
Blood Cancer Journal
All TP53 mutations are NOT equal: Does the "deleterious effect" of the TP53 mutation affect the outcome of Myelodysplastic Syndrome?
Evolutionary Action Score; TP53 mutation; Myelodysplastic Syndrome